What is Ayumetrix?
Ayumetrix operates at the intersection of clinical diagnostics and consumer wellness, providing a sophisticated platform for at-home hormone and health testing. The company distinguishes itself through the deployment of innovative, user-friendly collection devices that facilitate the analysis of hormone balance, infectious diseases, genetic markers, and food sensitivities. By bridging the gap between complex laboratory testing and accessible patient care, Ayumetrix serves a multifaceted ecosystem comprising individual patients, healthcare providers, corporate employers, and health plans. Their commitment to affordability and the delivery of visually intuitive diagnostic reports positions them as a critical infrastructure provider in the shift toward proactive, data-driven health management.
How much funding has Ayumetrix raised?
Ayumetrix has raised a total of $78K across 1 funding round:
Debt
$78K
Debt (2021): $78K with participation from PPP
Key Investors in Ayumetrix
PPP
Public-Private Partnership
What's next for Ayumetrix?
With the infusion of this recent capital, Ayumetrix is poised to accelerate its strategic roadmap, focusing on the expansion of its diagnostic menu and the enhancement of its proprietary testing technologies. The company is expected to prioritize the scaling of its logistics and digital reporting infrastructure to meet the rising demand for remote health monitoring. As the industry trends toward personalized medicine, Ayumetrix will likely leverage its current financial standing to forge deeper partnerships with health plans and enterprise clients, further embedding its diagnostic solutions into the standard of care for wellness-conscious populations. The focus remains on maintaining high-accuracy standards while driving down the cost of entry for comprehensive health insights.
See full Ayumetrix company page
